Jie Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jie Pan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Haifeng Shi
Department of Radiology, Peking Union Medical College Hospital, Beijing, China
1 shared publication - Xiaobo Zhang
Department of Radiology, Peking Union Medical College Hospital, Beijing, China
1 shared publication - Zhengyu Jin
Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
1 shared publication - Zhiwei Wang
State Key Laboratory of Tropical Crop Breeding, Sanya Institute of Breeding and Multiplication, School of Tropical Agriculture and Forestry, Hainan University, Sanya, China
1 shared publication
Latest Publications
- Open Access
- 24 June 2019
- Published by Springer Nature in Cancer Imaging
- Vol. 19 (1) , 1-5
Value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results
To evaluate the value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results. A retrospective analysis of the records of all patients with percutaneous bone biopsies based on PET/CT results and a final diagnosis of lymphoma between January 2012 and August 2017 was performed. Thirty-one patients were included in this study. The success and complication rates were assessed. The mean age of the 31 patients was 46.6 ± 21.2 years, and there were 16 men and 15 women. A definite diagnosis and accurate histological subtype were obtained in 26 patients, for a success rate of 84%. The most common subtype was diffuse large B cell lymphoma (n = 18). The remaining subtypes included three cases of marginal-zone lymphoma, two cases of follicular lymphoma, one case of Hodgkin’s lymphoma, one case of peripheral T cell lymphoma, and one case of B cell lymphoblastic lymphoma. No serious complications occurred in any of the patients. CT-guided needle biopsy based on PET/CT results is a reliable means of diagnosing and classifying lymphomas.
- 24 June 2019
- Published by Springer Nature in Cancer Imaging
- Vol. 19 (1) , 1-5
Open AccessValue of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results
To evaluate the value of CT-guided percutaneous needle biopsy of bone in the diagnosis of lymphomas based on PET/CT results. A retrospective analysis of the records of all patients with percutaneous bone biopsies based on PET/CT results and a final diagnosis of lymphoma between January 2012 and August 2017 was performed. Thirty-one patients were included in this study. The success and complication rates were assessed. The mean age of the 31 patients was 46.6 ± 21.2 years, and there were 16 men and 15 women. A definite diagnosis and accurate histological subtype were obtained in 26 patients, for a success rate of 84%. The most common subtype was diffuse large B cell lymphoma (n = 18). The remaining subtypes included three cases of marginal-zone lymphoma, two cases of follicular lymphoma, one case of Hodgkin’s lymphoma, one case of peripheral T cell lymphoma, and one case of B cell lymphoblastic lymphoma. No serious complications occurred in any of the patients. CT-guided needle biopsy based on PET/CT results is a reliable means of diagnosing and classifying lymphomas.